ArticleFrontiers in immunology2017

Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles.

Friederike Fuchs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.